Abstract
The aim of this study is to investigate macrophages polarization induced by methionine enkephalin (MENK) that promotes tumoricidal responses in vivo and in vitro. Both phenotypic and functional activities of macrophages were assessed by the quantitative analysis of key surface molecules on macrophages with flow cytometry, immunofluorescent staining, and the production of cytokines with enzyme-linked immunosorbent assay and reverse transcriptase-polymerase chain reaction. Our results showed that MENK could down-regulate the expression of CD206 and the production of arginase-1 (the markers of alternatively activated (M2) macrophage) in tumor-associated macrophages in vivo, meanwhile it could significantly up-regulate the expression of CD64, MHC-II, and the production of induced nitric oxide synthase (the markers of classically activated (M1) macrophages). Furthermore, the studies on bone marrow-derived macrophages treated with MENK (10−12 M) in vitro had demonstrated that MENK could markedly increase tumoricidal activity. MENK could also enhance the release of reactive oxidant species and the production of interleukin-12p40, tumor necrosis factor-α, while decrease the production of interleukin-10. In conclusion, MENK could effectively induce M2 macrophages polarizing to M1 macrophages, sequentially to modulate the Th1 responses of the host immune system. Our results suggest that MENK might have great potential as a new therapeutic agent for cancer.
Similar content being viewed by others
Abbreviations
- MENK:
-
Methionine enkephalin
- OGF:
-
Opioid growth factor
- TAM:
-
Tumor-associated macrophage
- BMDMs:
-
Bone marrow-derived macrophages
- GM-CSF:
-
Granulocyte macrophage colony stimulating factor
- IL-4:
-
Interleukin-4
- IL-12p40:
-
Interleukin-12p40
- IL-10:
-
Interleukin-10
- IFN-γ:
-
Interferon-γ
- TNF-α:
-
Tumor necrosis factor-α
- iNOS:
-
Induced nitric oxide synthase
- Arg-1:
-
Arginase-1
- ROS:
-
Reactive oxidant species
- FCM:
-
Flow cytometry
- RT-PCR:
-
Reverse transcriptase-polymerase chain reaction
- ELISA:
-
Enzyme-linked immunosorbent assay
References
Sharp BM (2006) Multiple opioid receptors on immune cells modulate intracellular signaling. Brain Behav Immun 20:9–14
Donahue RN, McLaughlin PJ, Zagon IS (2009) Cell proliferation of human ovarian cancer is regulated by the opioid growth factor-opioid growth factor receptor axis. Am J Physiol Regulatory Integrative Comp Physiol 296:R1716–R1725
Zagon IS, Donahue RN, McLaughlin PJ (2009) opioid growth factor-opioid growth factor receptor axis is a physiological determinant of cell proliferation in diverse human cancers. Am J Physiol Regulatory Integrative Comp Physiol 297:R1154–R1161
Piva M, Moreno JI, Jenkins FS, Smith JK, Thomas JL, Montgomery C, Wilson CB et al (2005) In vitro modulation of cytokine expression by enkephalin-derived peptide. Neuroimmuno-modulation 12:339–347
Zagon IS, Verderame MF, McLaughlin PJ (2002) The biology of the opioid growth factor receptor (OGFr). Brain Res Rev 38:351–376
Hatzoglou A, Kampa M, Castanas E (2005) Opioid–somatostatin interactions in regulating cancer cell growth. Frontiers in Bioscience 10:244–256
McLaughlin PJ, Stack BC, Braine KM, Ruda JD, Zagon IS (2004) Opioid growth factor (OGF) inhibition of a human squamous cell carcinoma of the head and neck in nude mice: dependency on the route of administration. Int J Oncol 24:227–232
Zagon IS, Jaglowski JR, Verderame MF, Smith JP, Leure-duPree AE, McLaughlin PJ (2005) Combination chemotherapy with gemcitabine and biotherapy with opioid growth factor (OGF) enhances the growth inhibition of pancreatic adenocarcinoma. Cancer Chemother Pharmacol 56:510–520
Naito M (2008) Macrophage differentiation and function in health and disease. Pathol Int 58:143–155
Mantovani A, Sica A, Locati M (2005) Macrophage polarization comes of age. Immunity 23:344–346
Gordon S (2009) Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol 27:451–483
Fengping S, Yanjie X, Ning W, Jingjuan M, Changlong L, Yiming M et al (2011) Functional modulation of the pathway between dendritic cells (DCs) and CD4+T cells by the neuropeptide: methionine enkephalin (MENK). Peptides 32:929–937
Quidville V, Segond N, Pidoux E, Cohen R, Jullienne A, Lausson S (2004) Tumor growth inhibition by indomethacin in a mouse model of human medullary thyroid cancer: implication of cyclooxygenases and 15-hydroxyprostaglandin dehydrogenase. Endocrinology 145:2561–2571
El-Gazzar A, Perco P, Eckelhart E, Anees M, Sexl V, Mayer B et al (2010) Natural immunity enhances the activity of a DR5 agonistic antibody and carboplatin in the treatment of ovarian cancer. Mol Cancer Ther 9:1007–1018
Umemura N, Saio M, Suwa T, Kitoh Y, Juncheng B, Nonaka K et al (2008) Tumor-infiltrating myeloid-derived suppressor cells are pleiotropic-inflamed monocytes/macrophages that bear M1- and M2-type characteristics. J Leukocyte Biology 83:1136–1144
Kang L, Wei X, Qiang G, Zhenggang J, Ping W, Yan Y et al (2009) Differential macrophage polarization in male and female BALB/c mice infected with coxsackievirus B3 defines susceptibility to viral myocarditis. Circ Res 105:353–364
Mittal R, Sukumaran SK, Selvaraj SK, Wooster DG, Babu MM, Schreiber AD et al (2010) Fcγ receptor I alpha chain (CD64) expression in macrophages is critical for the onset of meningitis by Escherichia coli K1. PLoS Pathog 6:e1001203
Wei W, Jing W, Sheng-fu D (2010) Immunomodulatory activity of andrographolide on macrophage activation and specific antibody response. Acta Pharmacol Sin 31:191–201
Nicolas M, Derya U, Dan RL (2008) The differentiation of human TH-17 cells requires transforming growth factor-b and induction of the nuclear receptor RORγt. Nat Immunol 9(6):641–649
Feng P, Yee KK, Rawson NE, Feldman LM, Feldman RS, Breslin PAS (2009) Immune cells of the human peripheral taste system: dominant dendritic cells and CD4 T-Cells. Brain Behav Immun 23:760–766
Martín L, Comalada M, Marti L, Closs EI, MacLeod CL, Río RM et al (2006) Granulocyte-macrophage colony-stimulating factor increases l-arginine transport through the induction of CAT2 in bone marrow-derived macrophages. Am J Physiol Cell Physiol 290:C1364–C1372
Sodhi A, Suresh A (1992) Production of reactive nitrogen intermediates by bone marrow-derived macrophages on treatment with cisplatin in vitro. Clin Exp Immunol 89:502–508
Stanojevića S, Vujićb V, Mitića K, Kuštrimović N, Jovanović VK, Miletić T et al (2008) Methionine-enkephalin modulation of hydrogen peroxide (H2O2) release by rat peritoneal macrophages involves different types of opioid receptors. Neuropeptides 42:147–158
Vujićb V, Stanojevića S, Dimitrijević M (2004) Methionine-enkephalin stimulates hydrogen peroxide and nitric oxide production in rat peritoneal macrophage: interaction of μ, δ and κ opioid receptors. NeuroImmunoModulation 1:392–402
Vats D, Mukundan L, Odegaard JI, Lina Z, Smith KL, Morel CR et al (2006) Oxidative metabolism and PGC-1beta attenuate macrophage-mediated inflammation. Cell Metab 4:13–24
Odegaard JI, Ricardo Gonzalez RR, Goforth MH, Morel CR, Subramanian V, Mukundan L et al (2007) Macrophage-specific PPAR controls alternative activation and improves insulin resistance. Nature 447:1116–1120
Kim K-R, Son E-W, Hee-Um S, Kim B-O, Rhee D-K, Pyo S (2003) Immune alterations in mice exposed to the herbicide simazine. J Toxicol Environ Health 66:1159–1173
Nathan C, Shiloh MU (2000) Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. Proc Natl Acad Sci USA 97:8841–8848
Zagon IS, Donahue RN, McLaughlin PJ (2009) opioid growth factor-opioid growth factor receptor axis is a physiological determinant of cell proliferation in diverse human cancers. Am J Physiol Regulatory Integrative Comp Physiol 297:R1154–R1161
Donahue RN, McLaughlin PJ, Zagon IS (2009) Cell proliferation of human ovarian cancer is regulated by the opioid growth factor-opioid growth factor receptor axis. Am J Physiol Regulatory Integrative Comp Physiol 296:R1716–R1725
Smith JP, Bingaman SI, Mauger DT (2010) Opioid growth factor improves clinical benefit and survival in patients with advanced pancreatic Cancer. J Clinical Trials 2:37–48
McLaughlin PJ, Jaglowski JR (2005) Enhanced growth inhibition of squamous cell carcinoma of the head and neck by combination therapy of paclitaxel and opioid growth factor. Int J Oncol 26:809–816
Gordon S, Taylor PR (2005) Monocyte and macrophage heterogeneity. Nat Rev Immunol 5:953–964
Al-Sarireh B, Eremin O (2000) Tumor-associated macrophages (TAMS): disordered function, immune suppression and pro-gressive tumor growth. J R Coll Surg Edinb 45:1–16
Sica A, Schioppa T, Mantovani A, Allavena P (2006) Tumor-associated macrophages are a distinct M2 polarised population promoting tumor progression: potential targets of anti-cancer therapy. Eur J Cancer 42:717–727
Mrass P, Takano H, Ng LG, Daxini S, Lasaro MO, Iparraguirre A et al (2006) Random migration precedes stable target cell interactions of tumor-infiltrating T cells. JEM 203:2749–2761
Leimgruber A, Berger C, Cortez-Retamozo V, Etzrodt M, Newton AP, Waterman P et al (2009) Behavior of endogenous tumor-associated macrophages assessed in vivo using a functionalized nanoparticlem. Neoplasia 11:459–468
Acknowledgments
This work was supported financially by National Natural Science Foundation of China, No. 30771990 (to Fengping Shan) and China Liaoning provincial foundation for international collaboration, No. 2006305007 (to Fengping Shan).
Conflict of interest
The authors declare that we have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chen, W., Liu, J., Meng, J. et al. Macrophage polarization induced by neuropeptide methionine enkephalin (MENK) promotes tumoricidal responses. Cancer Immunol Immunother 61, 1755–1768 (2012). https://doi.org/10.1007/s00262-012-1240-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00262-012-1240-6